Scinai Immunotherapeutics Statistics
Total Valuation
SCNI has a market cap or net worth of $2.97 million. The enterprise value is $3.16 million.
Important Dates
The last earnings date was Friday, November 22, 2024, before market open.
| Earnings Date | Nov 22, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SCNI has 838,578 shares outstanding. The number of shares has increased by 96.30% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 838,578 |
| Shares Change (YoY) | +96.30% |
| Shares Change (QoQ) | +25.87% |
| Owned by Insiders (%) | 7.76% |
| Owned by Institutions (%) | 0.26% |
| Float | 730,745 |
Valuation Ratios
The trailing PE ratio is 0.43.
| PE Ratio | 0.43 |
| Forward PE | n/a |
| PS Ratio | 4.48 |
| Forward PS | n/a |
| PB Ratio | 0.30 |
| P/TBV Ratio | 0.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 0.67 |
| EV / Sales | 7.00 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.12.
| Current Ratio | 1.16 |
| Quick Ratio | 0.83 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.61 |
Financial Efficiency
Return on equity (ROE) is 128.46% and return on invested capital (ROIC) is -36.15%.
| Return on Equity (ROE) | 128.46% |
| Return on Assets (ROA) | -33.22% |
| Return on Capital (ROIC) | -36.15% |
| Revenue Per Employee | $14,581 |
| Profits Per Employee | $151,484 |
| Employee Count | 31 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.99% in the last 52 weeks. The beta is 2.46, so SCNI's price volatility has been higher than the market average.
| Beta (5Y) | 2.46 |
| 52-Week Price Change | -40.99% |
| 50-Day Moving Average | 3.51 |
| 200-Day Moving Average | 4.06 |
| Relative Strength Index (RSI) | 57.01 |
| Average Volume (20 Days) | 12,121 |
Short Selling Information
| Short Interest | 1,791 |
| Short Previous Month | 11,766 |
| Short % of Shares Out | 0.21% |
| Short % of Float | 0.25% |
| Short Ratio (days to cover) | 0.09 |
Income Statement
In the last 12 months, SCNI had revenue of $452,000 and earned $4.70 million in profits. Earnings per share was $8.20.
| Revenue | 452,000 |
| Gross Profit | -413,000 |
| Operating Income | -8.20M |
| Pretax Income | -19.70M |
| Net Income | 4.70M |
| EBITDA | -6.96M |
| EBIT | -8.20M |
| Earnings Per Share (EPS) | $8.20 |
Full Income StatementBalance Sheet
The company has $1.03 million in cash and $1.23 million in debt, giving a net cash position of -$195,000 or -$0.23 per share.
| Cash & Cash Equivalents | 1.03M |
| Total Debt | 1.23M |
| Net Cash | -195,000 |
| Net Cash Per Share | -$0.23 |
| Equity (Book Value) | 10.00M |
| Book Value Per Share | 11.86 |
| Working Capital | 225,000 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$6.48 million and capital expenditures -$246,000, giving a free cash flow of -$6.93 million.
| Operating Cash Flow | -6.48M |
| Capital Expenditures | -246,000 |
| Free Cash Flow | -6.93M |
| FCF Per Share | -$8.26 |
Full Cash Flow StatementMargins
Gross margin is -91.37%, with operating and profit margins of -1,813.72% and 1,038.94%.
| Gross Margin | -91.37% |
| Operating Margin | -1,813.72% |
| Pretax Margin | 1,038.94% |
| Profit Margin | 1,038.94% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |